Health Condition 1: F205- Residual schizophrenia
Conditions
Interventions
Intervention1: Adjuvant cerebellar anodal tDCS: Patients in Treatment as Usual + tDCS group will be administered tDCS additionally. We will use a table top tDCS device. Each patient will receive 05 se
Sponsors
Dr Shilpa Mandal
Eligibility
Inclusion criteria
Inclusion criteria: Patients of Schizophrenia with negative symptoms aged between 18-60 years and consenting for the study will be enrolled. They will be randomized to receive treatment as usual+ adjuvant cerebellar anodal tDCS and treatment as usual+sham
Exclusion criteria
Exclusion criteria: 1. Those diagnosed with Neurodevelopmental disorders, Depressive disorders, OCD, Dissociative disorders, Eating disorders, Alcohol and Substance use disorders. 2. Neurological conditions like Movement disorders, Multiple sclerosis, Epilepsy, Cerebrovascular diseases and CNS infections. 3. Those having uncontrolled Diabetes, Hypertension or acute or chronic inflammatory conditions. 4. Those with history of endocrine diseases involving disorders of thyroid gland, parathyroid gland and adrenal gland. 5. Pregnant or lactating patients. 6. Those who have
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effect of adjunctive Cerebellar anodal tDCS on Negative SymptomsTimepoint: End of fifth session | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between duration of illness & improvement in negative symptoms after adjuvant cerebellar anodal tDCSTimepoint: End of fifth session | — |
Countries
India
Contacts
Public ContactShilpa Mandal
Armed Forces Medical College, Pune
Outcome results
None listed